↓ Skip to main content

Dove Medical Press

Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

Overview of attention for article published in Vascular Health and Risk Management, April 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
131 Dimensions

Readers on

mendeley
175 Mendeley
Title
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Published in
Vascular Health and Risk Management, April 2013
DOI 10.2147/vhrm.s33934
Pubmed ID
Authors

Bo Ahrén

Abstract

Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose control plan as a glucose-lowering strategy, where hypoglycemia may be a limitation for the therapy and also a factor underlying clinical inertia. Glucose-lowering medications that increase circulating insulin in a glucose-independent manner, such as insulin and sulfonylurea therapy, are the most common cause of hypoglycemia. However, other factors such as a delayed or missed meal, physical exercise, or drug or alcohol consumption may also contribute. Specific risk factors for development of hypoglycemia are old age, long duration of diabetes, some concomitant medication, renal dysfunction, hypoglycemia unawareness, and cognitive dysfunction. Hypoglycemia is associated with acute short-term symptoms related to either counterregulation, such as tachycardia and sweating, or to neuroglycopenia, such as irritability, confusion, and in severe cases stupor, coma, and even death. However, there are also long-term consequences of hypoglycemia such as reduced working capacity, weight gain, loss of self-confidence with reduced quality of life, and increased risk for cardiovascular diseases. For both the patients, the health care system, and the society at large, hypoglycemia carries a high cost. Strategies to mitigate the risk of hypoglycemia include awareness of the condition; education of patients, relatives, and health care providers; and selecting appropriate glucose-lowering medication that also judges the risk for hypoglycemia to prevent this complication. This article summarizes the current knowledge of hypoglycemia and its consequences with a special emphasis on its consequences for the choice of glucose-lowering therapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Brazil 1 <1%
Colombia 1 <1%
India 1 <1%
United States 1 <1%
Unknown 169 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 15%
Student > Bachelor 23 13%
Student > Ph. D. Student 18 10%
Researcher 17 10%
Other 14 8%
Other 32 18%
Unknown 45 26%
Readers by discipline Count As %
Medicine and Dentistry 61 35%
Nursing and Health Professions 15 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Biochemistry, Genetics and Molecular Biology 9 5%
Psychology 5 3%
Other 22 13%
Unknown 53 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2013.
All research outputs
#7,355,485
of 25,373,627 outputs
Outputs from Vascular Health and Risk Management
#243
of 804 outputs
Outputs of similar age
#59,896
of 212,987 outputs
Outputs of similar age from Vascular Health and Risk Management
#6
of 16 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 804 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,987 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.